PH12019502629A1 - Liquid composition including alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharide - Google Patents
Liquid composition including alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharideInfo
- Publication number
- PH12019502629A1 PH12019502629A1 PH12019502629A PH12019502629A PH12019502629A1 PH 12019502629 A1 PH12019502629 A1 PH 12019502629A1 PH 12019502629 A PH12019502629 A PH 12019502629A PH 12019502629 A PH12019502629 A PH 12019502629A PH 12019502629 A1 PH12019502629 A1 PH 12019502629A1
- Authority
- PH
- Philippines
- Prior art keywords
- endoscopic
- liquid
- pharmaceutically acceptable
- acceptable salt
- alginic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Materials For Medical Uses (AREA)
Abstract
The present invention relates to a liquid-phase composition containing alginic acid or a pharmaceutically acceptable salt thereof and a colloidal polysaccharide, the composition being suitable as a medical biomaterial for tissue restoration used to elevate mucosal tissue of stomach, bowels, or the like when the mucosal tissue is subjected to endoscopic excision, and more specifically, to a liquid-phase composition, which is a medical pharmaceutical composition to be injected into the submucosal layer in endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD), wherein the liquid-phase composition contains alginic acid having a weight average molecular weight of 100,000 to less than 200,000 or a pharmaceutically acceptable salt thereof, and a colloidal polysaccharide. According to the present invention, the liquid-phase composition can be effectively used as a local submucosal injection agent which superbly sustains injection-induced elevation of mucous membranes during endoscopic mucosal resection or endoscopic submucosal dissection.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170073128A KR101884467B1 (en) | 2017-06-12 | 2017-06-12 | Liquid composition comprising alginate or a pharmaceutically acceptable salt thereof, and polysaccharide colloids |
PCT/KR2018/006617 WO2018230915A1 (en) | 2017-06-12 | 2018-06-11 | Liquid-phase composition containing alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharide |
Publications (1)
Publication Number | Publication Date |
---|---|
PH12019502629A1 true PH12019502629A1 (en) | 2020-06-08 |
Family
ID=63251399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12019502629A PH12019502629A1 (en) | 2017-06-12 | 2019-11-22 | Liquid composition including alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharide |
Country Status (7)
Country | Link |
---|---|
US (1) | US11071807B2 (en) |
EP (1) | EP3639862A4 (en) |
JP (1) | JP6901657B2 (en) |
KR (1) | KR101884467B1 (en) |
CN (1) | CN110740761B (en) |
PH (1) | PH12019502629A1 (en) |
WO (1) | WO2018230915A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11679076B2 (en) * | 2020-08-06 | 2023-06-20 | T-ACE Medical Co., Ltd. | Composition for submucosal injection and preparation method thereof |
CN114377214A (en) * | 2022-03-01 | 2022-04-22 | 南京工业大学 | Injectable sodium alginate hydrogel for assisting EMR or ESD operation |
WO2023201575A1 (en) * | 2022-04-20 | 2023-10-26 | 江苏扬子江医疗科技股份有限公司 | Injection type hydrogel, preparation method therefor, and use of injection type hydrogel as submucosal injection for endoscope adjuvant treatment |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2005039672A1 (en) * | 2003-10-23 | 2007-02-22 | 株式会社信州Tlo | Method of thickening thickening composition and needle device |
US20050208134A1 (en) * | 2004-02-25 | 2005-09-22 | Shlomo Magdassi | Biocompatible polymeric beads and use thereof |
MX2009001608A (en) * | 2006-08-24 | 2009-02-23 | Unilever Nv | Liquid satiety enhancing composition. |
JP5613567B2 (en) * | 2007-11-29 | 2014-10-22 | ジェンザイム・コーポレーション | Endoscopic mucosal resection using purified reverse thermosensitive polymer |
WO2013077357A1 (en) | 2011-11-25 | 2013-05-30 | 日本製薬株式会社 | Submucosal cushioning agent |
KR101436406B1 (en) | 2011-12-29 | 2014-09-02 | 주식회사 안랩 | Client, server, system and method for updating data based on peer to peer |
CN103071181B (en) * | 2013-02-01 | 2015-04-29 | 刘昌桂 | Hydrogel as well as preparation method and purpose of hydrogel |
JP6099044B2 (en) * | 2013-03-26 | 2017-03-22 | 国立大学法人 大分大学 | Medical composition |
EP3013270A4 (en) * | 2013-06-26 | 2017-02-22 | Vicut Medical Devices Ltd. | Device, kit and method for prolonged lifting of a tissue during endoscopic procedure |
KR102077158B1 (en) | 2013-07-10 | 2020-02-13 | 삼성전자 주식회사 | Apparatus and method for operating message function which is associated memo function |
KR101531091B1 (en) | 2013-07-19 | 2015-06-24 | 유재원 | Injectable agent for tissue repair treatment comprising the substance polymerizing hydrophobic biocompatible polymer and hydrophilic biocompatible polymer |
US20150099928A1 (en) * | 2013-10-07 | 2015-04-09 | Boston Scientific Scimed, Inc. | Injectable compositions |
ITMI20131927A1 (en) * | 2013-11-20 | 2015-05-21 | Cosmo Technologies Ltd | EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTIONING AND / OR ENDOSCOPIC SUBMUCOSAL DISSECTION. EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTION AND / OR ENDOSCOPIC SUBMUCOSAL DISSECTION |
ITMI20131924A1 (en) * | 2013-11-20 | 2015-05-21 | Cosmo Technologies Ltd | EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC AND MUCOSAL RESECTIONING AND / OR |
KR20160033897A (en) * | 2014-09-19 | 2016-03-29 | 주식회사 덱스레보 | Composition for tissue repair treatment and methods of manufacturing the same |
KR20160043547A (en) | 2014-10-13 | 2016-04-22 | (주)에코팜 | Natural disinfection for horticultural crops produced thereby and method of manufacturing pesticides and natural disinfection and pesticides |
US10179190B2 (en) * | 2015-05-29 | 2019-01-15 | Boston Scientific Scimed, Inc. | Compositions and methods for treatment of tissue |
CN105251048A (en) * | 2015-10-16 | 2016-01-20 | 山东福瑞达医药集团公司 | Injectable cartilage tissue protection and repair material containing xanthan gum |
-
2017
- 2017-06-12 KR KR1020170073128A patent/KR101884467B1/en active IP Right Grant
-
2018
- 2018-06-11 CN CN201880038649.9A patent/CN110740761B/en active Active
- 2018-06-11 EP EP18818009.5A patent/EP3639862A4/en active Pending
- 2018-06-11 US US16/619,333 patent/US11071807B2/en active Active
- 2018-06-11 JP JP2019565475A patent/JP6901657B2/en active Active
- 2018-06-11 WO PCT/KR2018/006617 patent/WO2018230915A1/en unknown
-
2019
- 2019-11-22 PH PH12019502629A patent/PH12019502629A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2020523059A (en) | 2020-08-06 |
JP6901657B2 (en) | 2021-07-14 |
KR101884467B1 (en) | 2018-08-02 |
EP3639862A1 (en) | 2020-04-22 |
US11071807B2 (en) | 2021-07-27 |
CN110740761B (en) | 2022-10-25 |
US20200114047A1 (en) | 2020-04-16 |
CN110740761A (en) | 2020-01-31 |
EP3639862A4 (en) | 2021-04-07 |
WO2018230915A1 (en) | 2018-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019502629A1 (en) | Liquid composition including alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharide | |
Herrero et al. | Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 10 cm | |
JP2016514108A5 (en) | ||
JP2017505761A5 (en) | ||
JP2001192336A5 (en) | ||
EP2349367A4 (en) | Modified silk films containing glycerol | |
JP7203428B2 (en) | ECM hydrogel for treating esophageal inflammation | |
AR068302A1 (en) | PEPTIDES FOR VACCINES FOR CANCERS EXPRESSING ANTIGENS ASSOCIATED WITH TUMORS | |
JP6284163B2 (en) | Pharmaceutical composition for wound protection, hemostasis or prevention of adhesions in the gastrointestinal tract | |
JP2016518442A5 (en) | ||
AU2015287920A8 (en) | Micronized Wharton's Jelly | |
ZA202202410B (en) | Rna particles comprising polysarcosine | |
JP2015514778A5 (en) | ||
SV2011003907A (en) | ANTIMICROBIAL COMPOSITIONS | |
RU2016137292A (en) | FGF-18 COMPOUND DIAGRAM | |
CN102657650A (en) | Esomeprazole sodium lyophilized powder composition for injection and preparation method thereof | |
MD3905G2 (en) | Remedy of durable action in the form of gel for treatment of parodentium affections (variants) | |
KR102169251B1 (en) | A pharmaceutical composition | |
RU2007129571A (en) | COMPOSITIONS BASED ON SALTS OF HYALURONIC ACID FOR THE TREATMENT OF EPITELIAL INJURIES | |
Bartova et al. | Endoscopic treatment of a giant pedunculated angiolipofibroma of the distal duodenum | |
Harati et al. | THE USE OF PRONTOSAN® WOUND GEL X IN PARTIAL AND FULL THICKNESS BURNS REQUIRING SPLIT THICKNESS SKIN GRAFTS-AN INTERIM ANALYSIS (174) | |
TH1901007727A (en) | Liquid composition that includes algenic acid or the pharmaceutically recognized salt of that and very small polysaccharides. | |
Xu et al. | Mo2047 The Effectiveness of the Triamcinolone-Loaded Thermogel System to Prevent Esophageal Stricture After Endoscopic Submucosal Dissection in a Porcine Model | |
Parra-Blanco et al. | PTH-059 Circumferential esd for squamous oesophageal neoplasia using the double tunnel technique: an organ preserving procedure | |
Fujino et al. | Sa1419 Usefulness of a New Sphincterotome for the Endoscopic Submucosal Dissection of Colorectal Neoplasms |